-
Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma
Vallés-Martí, A., Mantini, G., Manoukian, P., Waasdorp, C., Sarasqueta, A. F., de Goeij-de Haas, R. R., Henneman, A. A., Piersma, S. R., Pham, T. V., Knol, J. C., Giovannetti, E., Bijlsma, M. F. & Jiménez, C. R., 27 Jun 2023, In: Cell reports. 42, 6, 112581.Research output: Contribution to journal › Article › Academic › peer-review
-
Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer
Dings, M. P. G., Manoukian, P., Waasdorp, C., Quik, J. S. E., Strijker, M., Lodestijn, S. C., van Neerven, S. M., Moreno, L. F., de Oliveira, R. L., Bonsing, B. A., Bruno, M. J., Busch, O. R., Doukas, M., van Eijck, C. H., Mohammad, N. H., de Hingh, I. H., Molenaar, Q. I., Besselink, M. G., Vermeulen, L., Medema, J. P., & 2 others, 1 Feb 2023, In: International Journal of Cancer. 152, 3, p. 511-523 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
Manoukian, P., Bijlsma, M. & van Laarhoven, H., 27 Sept 2021, In: Frontiers in cell and developmental biology. 9, 743907.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
